PAI-1 showed a similar increase in %change in deep-hypo in both T2D and controls between studies whilst, interestingly, CD40LG showed an increase %change in deep-hypo in controls between studies but, conversely, showed increase %change in mild-hypo in T2D. This evidence concerns the gene CD40LG and type 2 diabetes mellitus.